Apr 25, 2024
06:10

Form of Proxy for Annual General Meeting to be held on 13 June 2024

Proxy Forms

00882 - TIANJIN DEV

Mar 28, 2024
06:05

An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section

Overseas Regulatory Announcement - Other

00882 - TIANJIN DEV

Mar 27, 2024
12:26

List of Directors and their Roles and Functions

List of Directors and their Role and Function

00882 - TIANJIN DEV

Mar 27, 2024
12:20

Change of Chairman of the Board, Authorised Representative and Change in Composition of Nomination Committee, Remuneration Committee and Investment Committee

Change of Remuneration Committee Member

00882 - TIANJIN DEV

Mar 27, 2024
12:14

Final Dividend for the year ended 31 December 2023

Dividend or Distribution (Announcement Form)

00882 - TIANJIN DEV

Mar 27, 2024
12:09

Annoucement of Final Results for the year ended 31 December 2023

Amendment of Constitutional Documents

00882 - TIANJIN DEV

Mar 22, 2024
06:10

Audited Financial Results for the year ended 31 December 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.

Results of a Subsidiary

00882 - TIANJIN DEV

Mar 15, 2024
19:12

Date of Board Meeting

Date of Board Meeting

00882 - TIANJIN DEV